Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenguang He

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
Plos Pathogens|May 26, 2017
Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variantsWei Zhang, Ben A Bailey-Elkin, Robert C M Knaap, et al.
Nature Communications|November 2, 2021
The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitorsTeklab Gebregiworgis, Yoshihito Kano, Jonathan St-Germain, et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
Plos Pathogens|May 26, 2017
Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variantsWei Zhang, Ben A Bailey-Elkin, Robert C M Knaap, et al.
Nature Communications|November 2, 2021
The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitorsTeklab Gebregiworgis, Yoshihito Kano, Jonathan St-Germain, et al.
Pageof 6